Paritaprevir
CAY-28301-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
1216941-48-8
Formulation
A solid
Purity
≥98%
MW
765,8784
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An orally bioavailable, direct-acting inhibitor of HCV NS3/4A serine protease; inhibits HCV replication in stable Huh7-derived replicon cell lines infected with subgenomic genotypes 1a, 1b, 2a, 3a, 4a, and 6a (EC50s = 1, 0.21, 5.3, 19, 0.09, and 0.69 nM, respectively); inhibits replicons from clinical isolates of genotypes 1a (EC50s = 0.43 to 1.87 nM) and 1b (EC50s = 0.033 to 0.087 nM)
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
